The recovery period of acute cerebral infarction
Conditions
Interventions
Experimental Group 1:Longxue Tongluo Capsules, oral, 2 capsules each time, three times a day
Control group:Enteric-coated aspirin tablets, oral, 1 tablet each time, once a day
Experimental Group 2:Longxue Tongluo Capsules, oral, 2 capsules each time, three times a day
Enteric-coated aspirin tablets, oral, 1 tablet each time, once a day
Sponsors
Lianyungang First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 120 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for cerebral infarction in Western medicine; (2) The course of this illness does not exceed 28 days. (3) Agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with progressive stroke transient ischemic attack cerebral hemorrhage after cerebral infarction and cerebral arteritis; (2) Patients with concurrent brain tumors brain trauma brain parasitic diseases etc. (3) Pregnant or lactating women; (4) Those who are allergic to the known components of the drug used in this study; (5) Active ulcers and those with a tendency to bleed; (6) Patients whom the researchers consider unsuitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of platelet aggregation function;Thromboelastography;Four items of thrombosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| The change of NIHSS score after 28 days of medication compared with the baseline;The proportion of no significant disability (grade 0-2) on the modified Rankin scale after 28 days of medication; | — |
Countries
China
Contacts
Public ContactHe Mingli
Lianyungang First People's Hospital
Outcome results
None listed